Live attenuated vaccine efficacy six months after intravenous immunoglobulin therapy for Kawasaki disease
2016 ◽
Vol 23
(2)
◽
pp. 162-166
2014 ◽
Vol 133
(2)
◽
pp. AB227
2006 ◽
Vol 148
(3)
◽
pp. 399-400
◽
2003 ◽
Vol 45
(2)
◽
pp. 156-158
◽
2015 ◽
Vol 11
(7)
◽
pp. 819-825
◽
Parameters to Guide Retreatment After Initial Intravenous Immunoglobulin Therapy in Kawasaki Disease
2011 ◽
Vol 41
(7)
◽
pp. 379
◽